148 related articles for article (PubMed ID: 36750933)
1. EIF5A2 specifically regulates the transcription of aging-related genes in human neuroblastoma cells.
Liu Y; Peng L; Chen J; Chen L; Wu Y; Cheng M; Chen M; Ye X; Jin Y
BMC Geriatr; 2023 Feb; 23(1):83. PubMed ID: 36750933
[TBL] [Abstract][Full Text] [Related]
2. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis.
Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic Initiation Factor 5A2 Regulates Expression of Antiviral Genes.
Farache D; Liu L; Lee ASY
J Mol Biol; 2022 May; 434(10):167564. PubMed ID: 35358571
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional induction of the human asparagine synthetase gene during the unfolded protein response does not require the ATF6 and IRE1/XBP1 arms of the pathway.
Gjymishka A; Su N; Kilberg MS
Biochem J; 2009 Feb; 417(3):695-703. PubMed ID: 18840095
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
[TBL] [Abstract][Full Text] [Related]
6. Sonic Hedgehog-GLI Family Zinc Finger 1 Signaling Pathway Promotes the Growth and Migration of Pancreatic Cancer Cells by Regulating the Transcription of Eukaryotic Translation Initiation Factor 5A2.
Xu X; Liu H; Zhang H; Dai W; Guo C; Xie C; Wei S; He S; Xu X
Pancreas; 2015 Nov; 44(8):1252-8. PubMed ID: 26465952
[TBL] [Abstract][Full Text] [Related]
7. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma.
Lee NP; Tsang FH; Shek FH; Mao M; Dai H; Zhang C; Dong S; Guan XY; Poon RT; Luk JM
Int J Cancer; 2010 Aug; 127(4):968-76. PubMed ID: 19998337
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
Dong JS; Wu B; Zha ZL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
[TBL] [Abstract][Full Text] [Related]
10. [Effects of eukaryotic translation initiation factor 5A2 down-regulation by small interfering RNA on aggressiveness of MKN28 human].
Meng QB; Yu JC; Kang WM; Ma ZQ; Zhou L; Ye X; Cao ZJ; Tian SB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):482-7. PubMed ID: 25360644
[TBL] [Abstract][Full Text] [Related]
11. Cryptotanshinone deregulates unfolded protein response and eukaryotic initiation factor signaling in acute lymphoblastic leukemia cells.
Wu CF; Seo EJ; Klauck SM; Efferth T
Phytomedicine; 2016 Feb; 23(2):174-80. PubMed ID: 26926179
[TBL] [Abstract][Full Text] [Related]
12. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
Li X; He J; Ren X; Zhao H; Zhao H
Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
[TBL] [Abstract][Full Text] [Related]
14. Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition.
Bao Y; Lu Y; Wang X; Feng W; Sun X; Guo H; Tang C; Zhang X; Shi Q; Yu H
Cancer Cell Int; 2015; 15():109. PubMed ID: 26581310
[TBL] [Abstract][Full Text] [Related]
15. MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer.
Tian SB; Yu JC; Liu YQ; Kang WM; Ma ZQ; Ye X; Yan C
World J Gastroenterol; 2015 Aug; 21(31):9337-47. PubMed ID: 26309359
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer.
Meng QB; Kang WM; Yu JC; Liu YQ; Ma ZQ; Zhou L; Cui QC; Zhou WX
PLoS One; 2015; 10(3):e0119229. PubMed ID: 25793713
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
19. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K
J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-9 Enhanced Cisplatin Sensitivity in Nonsmall Cell Lung Cancer Cells by Regulating Eukaryotic Translation Initiation Factor 5A2.
Pan Q; Sun L; Zheng D; Li N; Shi H; Song J; Shao G; Xu G
Biomed Res Int; 2018; 2018():1769040. PubMed ID: 30175116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
